| Identification | Back Directory | [Name]
Brasofensine | [CAS]
171655-91-7 | [Synonyms]
CID9554198
Brasofensine
UNII-1YP2S94RVH
8-Azabicyclo[3.2.1]octane-2-carboxaldehyde, 3-(3,4-dichlorophenyl)-8-methyl-, O-methyloxime, [1R-[1α,2β(E),3α,5α]]- | [Molecular Formula]
C16H20Cl2N2O | [MDL Number]
MFCD00944914 | [MOL File]
171655-91-7.mol | [Molecular Weight]
327.253 |
| Hazard Information | Back Directory | [Uses]
Brasofensine (BMS-204756) is an oral active dopamine transporter antagonist and can be used for parkinson’s disease research[1]. | [References]
[1] rackiewicz, E. J, et al. Brasofensine Treatment for Parkinson’s Disease in Combination with Levodopa/Carbidopa. Annals of Pharmacotherapy, 36(2), 225–230. DOI:10.1345/aph.1A152 |
|
| Company Name: |
LGM Pharma
|
| Tel: |
1-(800)-881-8210 |
| Website: |
www.lgmpharma.com |
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Website: |
https://www.bocsci.com |
|